Public investment bank Bpifrance is buying a €95m stake in France’s third largest hospital operator MédiPôle Partenaires. Expect more consolidation, says Xavier Dumont, CFO at MédiPôle Partenaires.
The Belgian REIT Cofinimmo announced €25m worth of investment this week, and indicated the European healthcare property market is pivoting towards Germany, as a steady flow of acquisitions continues there, yet prove scarce elsewhere on the continent.
French lab group Cerba will be sold by its private equity owner PAI Partners in the autumn, reports the French daily Les Echos. It could fetch up to 13 times EBITDA from either European PE buyers, Canadian pension funds or emerging market buyers, and Natixiis and JP Morgan are handling the sale process, it reports.
Paris-listed care groups Korian and Orpea, the two largest in Europe, released solid half-year results this week. The former reiterated its €3bn full-year sales target for 2016, whilst the latter revised it upwards by €90m to €2.81bn.
We hear that Prudential and Aviva, the third and fourth players in the UK private medical insurance market, are planning to share their healthcare data. Our sources say that unless they can share they are at a serious disadvantage to the top two players, Bupa and Axa.
Bioanalytic testing outfit Eurofins Scientific has just raised €200m through a private placement with La Caisse des Dépôts et placement du Québec (“CDPQ”), one of Canada’s largest institutional fund managers. CDPQ and other institutions have also said they are happy to dip into their pockets to fund more acquisitions. West European lab/imaging group Unilabs could be a target.
French nursing homes are finding new ways to reduce costs –and get more patients. That means more homecare, more day care and more remote care, according to Philippe Tapié, CEO of France’s fourth largest elderly care group Maisons de Famille, who has just bought Spanish chain Amma for an estimated €230m.
The French private hospital sector is excluded from the latest plans to consolidate public hospitals through the creation of Groupements Hospitaliers de Territoire (GHT). Is this yet another indicator that the government is marginalising the private sector?
The price of some popular genetic tests have all but halved in little more than a year. B2C web sites are now springing up offering ever lower prices as Chinese operators enter the European market. So what does this mean for diagnostic lab groups who have for so long prophesied that complex genetic testing will […]
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
